MA25832A1 - Sel de tartrate d'un derive de thiazolidinedione. - Google Patents
Sel de tartrate d'un derive de thiazolidinedione.Info
- Publication number
- MA25832A1 MA25832A1 MA27024A MA27024A MA25832A1 MA 25832 A1 MA25832 A1 MA 25832A1 MA 27024 A MA27024 A MA 27024A MA 27024 A MA27024 A MA 27024A MA 25832 A1 MA25832 A1 MA 25832A1
- Authority
- MA
- Morocco
- Prior art keywords
- tartrate
- salt
- thiazolidinedione derivative
- thiazolidinedione
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0019224.5A GB0019224D0 (en) | 2000-08-04 | 2000-08-04 | Novel pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
MA25832A1 true MA25832A1 (fr) | 2003-07-01 |
Family
ID=9897026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27024A MA25832A1 (fr) | 2000-08-04 | 2003-02-03 | Sel de tartrate d'un derive de thiazolidinedione. |
Country Status (37)
Country | Link |
---|---|
US (1) | US20040014790A1 (fr) |
EP (1) | EP1305311B1 (fr) |
JP (1) | JP2004505970A (fr) |
KR (1) | KR100755174B1 (fr) |
CN (1) | CN1455778A (fr) |
AP (1) | AP1785A (fr) |
AT (1) | ATE384059T1 (fr) |
AU (1) | AU2001276506A1 (fr) |
BG (1) | BG107604A (fr) |
BR (1) | BR0112982A (fr) |
CA (1) | CA2417827A1 (fr) |
CY (1) | CY1107252T1 (fr) |
CZ (1) | CZ2003313A3 (fr) |
DE (1) | DE60132461T2 (fr) |
DK (1) | DK1305311T3 (fr) |
DZ (1) | DZ3418A1 (fr) |
EA (1) | EA005408B1 (fr) |
EC (1) | ECSP034467A (fr) |
ES (1) | ES2296772T3 (fr) |
GB (1) | GB0019224D0 (fr) |
HK (1) | HK1057358A1 (fr) |
HR (1) | HRP20030068B1 (fr) |
HU (1) | HUP0300778A3 (fr) |
IL (2) | IL154275A0 (fr) |
MA (1) | MA25832A1 (fr) |
MX (1) | MXPA03001085A (fr) |
NO (1) | NO324596B1 (fr) |
NZ (1) | NZ524030A (fr) |
OA (1) | OA12354A (fr) |
PL (1) | PL360662A1 (fr) |
PT (1) | PT1305311E (fr) |
SI (1) | SI1305311T1 (fr) |
SK (1) | SK1462003A3 (fr) |
UA (1) | UA76720C2 (fr) |
WO (1) | WO2002012232A1 (fr) |
YU (1) | YU14603A (fr) |
ZA (1) | ZA200300961B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
DE102005034406A1 (de) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | Neue Salze von Rosiglitazon |
US7435741B2 (en) * | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
CN108348292B (zh) | 2015-10-27 | 2021-04-27 | 纳诺帕斯技术有限公司 | 具有机械性导引的微针装置 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-08-04 GB GBGB0019224.5A patent/GB0019224D0/en not_active Ceased
-
2001
- 2001-03-08 UA UA2003020938A patent/UA76720C2/uk unknown
- 2001-08-03 IL IL15427501A patent/IL154275A0/xx active IP Right Grant
- 2001-08-03 OA OA1200300028A patent/OA12354A/en unknown
- 2001-08-03 DZ DZ013418A patent/DZ3418A1/fr active
- 2001-08-03 NZ NZ524030A patent/NZ524030A/en unknown
- 2001-08-03 WO PCT/GB2001/003511 patent/WO2002012232A1/fr active IP Right Grant
- 2001-08-03 CZ CZ2003313A patent/CZ2003313A3/cs unknown
- 2001-08-03 EA EA200300230A patent/EA005408B1/ru not_active IP Right Cessation
- 2001-08-03 ES ES01954159T patent/ES2296772T3/es not_active Expired - Lifetime
- 2001-08-03 US US10/343,845 patent/US20040014790A1/en not_active Abandoned
- 2001-08-03 DE DE60132461T patent/DE60132461T2/de not_active Expired - Fee Related
- 2001-08-03 MX MXPA03001085A patent/MXPA03001085A/es active IP Right Grant
- 2001-08-03 SK SK146-2003A patent/SK1462003A3/sk unknown
- 2001-08-03 HU HU0300778A patent/HUP0300778A3/hu unknown
- 2001-08-03 JP JP2002518207A patent/JP2004505970A/ja not_active Withdrawn
- 2001-08-03 AU AU2001276506A patent/AU2001276506A1/en not_active Abandoned
- 2001-08-03 SI SI200130808T patent/SI1305311T1/sl unknown
- 2001-08-03 YU YU14603A patent/YU14603A/sh unknown
- 2001-08-03 CA CA002417827A patent/CA2417827A1/fr not_active Abandoned
- 2001-08-03 EP EP01954159A patent/EP1305311B1/fr not_active Expired - Lifetime
- 2001-08-03 DK DK01954159T patent/DK1305311T3/da active
- 2001-08-03 CN CN01815600A patent/CN1455778A/zh active Pending
- 2001-08-03 PT PT01954159T patent/PT1305311E/pt unknown
- 2001-08-03 AT AT01954159T patent/ATE384059T1/de not_active IP Right Cessation
- 2001-08-03 BR BR0112982-1A patent/BR0112982A/pt not_active IP Right Cessation
- 2001-08-03 PL PL36066201A patent/PL360662A1/xx not_active Application Discontinuation
- 2001-08-03 KR KR1020037001604A patent/KR100755174B1/ko not_active IP Right Cessation
- 2001-08-03 AP APAP/P/2003/002736A patent/AP1785A/en active
-
2003
- 2003-02-03 NO NO20030530A patent/NO324596B1/no not_active IP Right Cessation
- 2003-02-03 HR HR20030068A patent/HRP20030068B1/xx not_active IP Right Cessation
- 2003-02-03 IL IL154275A patent/IL154275A/en not_active IP Right Cessation
- 2003-02-03 MA MA27024A patent/MA25832A1/fr unknown
- 2003-02-04 ZA ZA200300961A patent/ZA200300961B/en unknown
- 2003-02-04 EC EC2003004467A patent/ECSP034467A/es unknown
- 2003-02-28 BG BG107604A patent/BG107604A/bg unknown
- 2003-10-24 HK HK03107709A patent/HK1057358A1/xx not_active IP Right Cessation
-
2008
- 2008-03-19 CY CY20081100309T patent/CY1107252T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU92890I2 (fr) | Panobinstat ou un sel pharmaceutiquement acceptable, ou un dérivé de celui-ci (farydak) | |
LU92678I2 (fr) | Tobramycine ou un sel pharmaceutiquement acceptable qui en dérive | |
LU93266I2 (fr) | Sélexipag ou un sel de celui-ci | |
LU92439I2 (fr) | Vilanterol ou un sel ou un solvate de celui-ci | |
LU92702I2 (fr) | Naloxegol ou un sel pharmaceutiquement acceptable de celui-ci (moventig) | |
LU92397I2 (fr) | Vortioxétine ou un sel d'addition d'acide de celui-ci pharmaceutiquement acceptable | |
BR0000327B1 (pt) | cabeÇa de poÇo. | |
DZ3001A1 (fr) | Sel de potassium d'oméprazole-(S). | |
DE60125004D1 (de) | Verbesserte Reinigungsverfahren eines Druckkopfes | |
MA25898A1 (fr) | SELS DE TARTRATE D'UN DERIVé DE THIAZOLIDINEDIONE. | |
MA25830A1 (fr) | Sel de tartrate d'un derive de thiazolidinedione. | |
MA25832A1 (fr) | Sel de tartrate d'un derive de thiazolidinedione. | |
MA25831A1 (fr) | Sel de tartrate d'un derive de thiazolidinedione. | |
EG22745A (en) | 2-(3,5-Disbustituted-4-pyridyl)-4-(thienyl) thiazolyl or arylphenyl)1,30xazoline compounds | |
IL151017A0 (en) | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor | |
FR2809397B1 (fr) | Procede de preparation d'un compose de type benzofuranne ou benzothiophene | |
SI1305310T1 (sl) | Tartratne soli derivata tiazolidindiona | |
IT1311483B1 (it) | Tavolo per un gioco di bilie. | |
IT250149Y1 (it) | Dispositivo per l'applicazione di un prodotto | |
IT1314214B1 (it) | Forma per getti di colatura. | |
FR2826662B1 (fr) | Procede de preparation d'un sel de polyaniline |